A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)
Public ClinicalTrials.gov record NCT04795531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-week Double Blinded, Multiregional, Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Degludec 100 Units/mL, Both in Combination With Non-insulin Anti-diabetic Drugs, in Insulin naïve Subjects With Type 2 Diabetes.
Study identification
- NCT ID
- NCT04795531
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 588 participants
Conditions and interventions
Conditions
Interventions
- Insulin degludec Drug
- Insulin icodec Drug
- Placebo insulin degludec Drug
- Placebo insulin icodec Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2021
- Primary completion
- Jun 22, 2022
- Completion
- Jun 22, 2022
- Last update posted
- Dec 3, 2024
2021 – 2022
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lakeview Clinical Research, LLC | Guntersville | Alabama | 35976 | — |
| American Clinical Trials | Buena Park | California | 90620 | — |
| Headlands Research California, LLC | Escondido | California | 92025 | — |
| Valley Research | Fresno | California | 93720 | — |
| First Valley Medical Group | Lancaster | California | 93534 | — |
| Est Cst Inst for Rsrch,Jksnvil | Jacksonville | Florida | 32216 | — |
| Palm Harbor Medical Associates | Palm Harbor | Florida | 34684-3609 | — |
| Metabolic Research Institute Inc | West Palm Beach | Florida | 33401 | — |
| Cedar-Crosse Research Center | Chicago | Illinois | 60607 | — |
| Cotton-Oneill Diabetes and End | Topeka | Kansas | 66606-2806 | — |
| Arcturus Healthcare, PLC | Troy | Michigan | 48098 | — |
| Southgate Medical Group, LLP | West Seneca | New York | 14224 | — |
| Physician's East Endocrinology | Greenville | North Carolina | 27834 | — |
| Accellacare | Wilmington | North Carolina | 28401 | — |
| Diab & Endo Assoc of Stark Co | Canton | Ohio | 44718 | — |
| Providence Health Partners Ctr | Dayton | Ohio | 45439 | — |
| Prestige Clinical Research | Franklin | Ohio | 45005 | — |
| Intend Research | Norman | Oklahoma | 73069 | — |
| Hillcrest Clinical Research | Simpsonville | South Carolina | 29681-1538 | — |
| Velocity Clinical Res-Dallas | Dallas | Texas | 75230 | — |
| UT Southwestern Med Cntr | Dallas | Texas | 75390-9302 | — |
| PrimeCare Medical Group | Houston | Texas | 77024 | — |
| Texas Diab & Endo, P.A. | Round Rock | Texas | 78681 | — |
| Clinical Trials of Texas, LLC | San Antonio | Texas | 78229 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| Rainier Clin Res Ctr Inc | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04795531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2024 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04795531 live on ClinicalTrials.gov.